OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 45 filers reported holding OMEGA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,907,087 | -61.7% | 887,017 | -0.1% | 0.07% | -57.2% |
| Q2 2023 | $4,974,676 | -10.6% | 888,335 | -3.8% | 0.17% | -10.4% |
| Q1 2023 | $5,567,445 | +67.0% | 923,291 | +58.2% | 0.19% | +52.0% |
| Q4 2022 | $3,333,144 | -2.5% | 583,738 | -7.5% | 0.13% | -11.2% |
| Q3 2022 | $3,420,000 | +29.6% | 631,079 | -9.1% | 0.14% | +43.0% |
| Q2 2022 | $2,639,000 | +2.0% | 694,431 | +67.5% | 0.10% | +26.6% |
| Q1 2022 | $2,587,000 | -44.9% | 414,513 | 0.0% | 0.08% | -39.7% |
| Q4 2021 | $4,696,000 | -50.2% | 414,513 | -17.1% | 0.13% | -50.6% |
| Q3 2021 | $9,425,000 | – | 500,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
| CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
| Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
| HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
| Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
| Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
| Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
| Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |